¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"latent carrier"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hod carrier¡¯s palsy
    È£µå¿î¹ÝÀÚ¸¶ºñ
  • incubatory carrier
    Àẹ±âº¸±ÕÀÚ
  • intermittent carrier
    °£Ç溸±ÕÀÚ
  • permanent carrier
    ¿µ±¸º¸±ÕÀÚ
  • silent carrier
    ¹«Áõ»óº¸ÀÎÀÚ
  • latent
    ÀáÀç-, Àẹ-
  • latent beriberi
    Àẹ°¢±âº´
  • latent content
    ÀáÀç³»¿ë
  • latent diabetes
    ÀáÀç´ç´¢º´
  • latent empyema
    ÀáÀç°¡½¿°í¸§Áý, ÀáÀç³óÈä
  • latent epilepsy
    ÀáÀç°£Áú
  • latent fingerprint
    ÀáÀçÁö¹®
  • latent gout
    ÀáÀçÅëdz
  • latent hyperopia
    Àẹ¿ø½Ã
  • latent immunization
    ÀáÀç¸é¿ªÈ­
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heterozygous carrier
    ÀÌÁ¾Á¢ÇÕº¸ÀÎÀÚ
  • incubatory carrier
    Àẹ±âº¸±ÕÀÚ
  • intermittent carrier
    °£Ç溸±ÕÀÚ
  • permanent carrier
    ¿µ±¸º¸±ÕÀÚ
  • silent carrier
    ¹«Áõ»óº¸ÀÎÀÚ
  • hepatitis carrier state
    °£¿°º¸±ÕÀÚ»óÅÂ
  • hod carrier¡¯s palsy
    Àâ¿ë¿î¹ÝÀÚ¸¶ºñ
  • latent beriberi
    Àẹ°¢±â
  • latent content
    ÀáÀç³»¿ë
  • latent deficiency
    ÀáÀç°áÇÌÁõ
  • latent diabetes
    ÀáÀç´ç´¢º´
  • latent empyema
    ÀáÀç°í¸§Áý, ÀáÀç³óÈä
  • latent epilepsy
    Àẹ°£Áú
  • latent fingerprint
    ÀáÀçÁö¹®
  • latent gout
    ÀáÀçÅëdz
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • latent epilepsy
    Àẹ°£Áú(íÖÜÑÊÖòð).
  • latent finger-print
    ÇöÀåÁö¹®(úÞíÞò¦Ú£).
  • latent gout
    ÀáÀ缺 Åëdz(íÖî¤àõ÷Ôù¦).
  • latent heat
    Àá¿­(íÖæð).
  • latent heat
    Àá¿­(ËöËç).
  • latent heat of fusion
    À¶ÇØ(ë×ú°)Àá¿­.
  • latent hypermetropia
    Àẹ¿ø½Ã
  • latent hyperopia
    Àẹ¿ø½Ã
  • latent infection
    Àẹ°¨¿°(íÖÜÑÊïæø).
  • latent infection
    Àẹ°¨¿°, ÀáÀç°¨¿°, È޸鰨¿°
  • latent jaundice
    ÀáÀ缺 Ȳ´Þ(íÖî¤àõüÜÓ¸).
  • latent microbism
    Àẹ°¨¿°(ÊÙ˧Ëç).
  • latent nystagmus
    Àẹ¾ÈÁø
  • latent nystagmus
    Àẹ¾ÈÁø(¡­äÑòè).
  • latent period
    Àẹ±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • C55 lipid carrier
    "C55 ÁöÁú¿î¹Ýü(ò·òõê¡Úæô÷),(ÔÒ) bactoprenol"
  • electrogenic carrier
    Àü±â»ý¼º ¿î¹ÝÀÚ(ï³Ñ¨ßæà÷ê¡Úæí­)
  • electron carrier
    ÀüÀÚ¿î¹ÝÀÚ(ï³í­ê¡Úæí­)
  • electrophoretic carrier
    Àü±â¿µµ¿ ¿î¹ÝÀÚ(ï³Ñ¨ç¶ÔÑê¡Úæí­)
  • hydrogen carrier
    ¼ö¼Ò ¿î¹ÝÀÚ(â©áÈê¡Úæí­)
  • ion carrier
    À̿ ¿î¹Ýü(ê¡Úæô÷)
  • membrane carrier
    ¸·¿î¹Ýü(دê¡Úæô÷)
  • mobile carrier
    À̵¿¿î¹Ýü(ì¹ÔÑê¡Úæô÷)
  • mobile ion carrier
    À̵¿(ì¹ÔÑ)À̿¿î¹Ýü(ê¡Úæô÷)
  • oxygen carrier
    »ê¼Ò ¿î¹Ýü(ß«áÈê¡Úæô÷)
  • phosphoryl-group carrier
    ÀλêÈ­±â ¿î¹Ýü(×òß«ûùÐñê¡Úæô÷)
  • redox carrier
    ·¹µ¶½º ¿î¹ÝÀÚ(ê¡Úæíº)
  • sterol carrier protein
    ½ºÅ×·Ñ ¿î¹Ýü ´Ü¹éÁú(ê¡Úæô÷Ó±ÛÜòõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EAAC excitatory amino acid carrier
PCC Pasteur Culture Collection; percutaneous cecostomy; pheochromocytoma; phosphate carrier compound; pl...
RCP red cell protoporphyrin; retrocorneal pigmentation; riboflavin carrier protein; Royal College of Phy...
SCP single-celled protein; standard care plan; sodium cellulose phosphate; soluble cytoplasmic protein; ...
SPC salicylamide, phenacetin, and caffeine; seropositive carrier; single palmar crease; single photoelec...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LMP1 Latent infection membrane protein 1
LMP1 Latent membrane protein
LMP-2A Latent membrane protein 2A
PLMVd Peach latent mosaic viroid
PLS Projections to Latent Structures
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • latent bone cavity
    Àẹ¼º °ñ ³¶
  • latent carcinoma
    ÀáÀ缺 ¾Ï
    ºÐ¸íÈ÷ ¾ÏÀÌÁö¸¸ ÀÓ»óÀûÀ¸·Î Áõ»óÀÌ ¾øÀ¸¸ç, ¿¬·É Áõ°¡ ½Ã ÇÔ²² Áõ°¡ÇÑ´Ù.
  • latent diabetes
    ÀáÀ缺 ´ç´¢º´
  • latent factor
    ÀáÀçÀû ¿ä¼Ò
  • latent finger-print
    ÇöÀå Áö¹®
    »ç°Ç ÇöÀå¿¡ ³²¾ÆÀÖ´Â Áö¹®.
  • latent heat of fusion
    À¶ÇØ Àá¿­
    ¹°ÁúÀÌ ³ì´Â °úÁ¤¿¡¼­ ¿ÂµµÀÇ º¯È­¸¦ ¼ö¹ÝÇÏÁö ¾Ê°í Èí¼ö ¶Ç´Â ¹æÃâµÇ´Â ¿­·®.
  • latent image
    ˇȗ
    »çÁø¿¡¼­, ³ëÃâÇÑ ÈÄ ¾ÆÁ÷ Çö»óÇÏÁö ¾ÊÀº Çʸ§ÀÇ °¨±¤¸· °¡¿îµ¥ ÀÖ´Â ÇÇ»çüÀÇ ¿µ»ó.
  • latent myofascial trigger point
    ÀáÀ缺 ±Ù¸· ¹ßÅëÁ¡
    ÃËÁø¿¡ ÀÇÇØ ÅëÁõÀÌ ³ªÅ¸³ª´Â °ÍÀ» Æ÷ÇÔÇÏ¿© Ȱµ¿¼º ±Ù¸· ¹ßÅëÁ¡ÀÇ ¸ðµç Ư¼ºÀ» °¡ÁöÁö¸¸ Àڹ߼ºÀÇ ÀÓ»óÀû ÅëÁõÀ̳ª Áõ»óÀÇ ¿øÀÎÀÌ µÇÁö´Â ¾Ê´Â ±Ù¸· ¹ßÅëÁ¡.
  • latent period
    Àẹ±â, Àẹ½Ã, ÀáÀڱؽÃ, Àẹ ±â°£
    ¿Ü°ü»ó ºÒȰ¼ºÈ­ µÈ ±â°£. Á¶Á÷ÀÌ À¯ÇØ ¹°Áú¿¡ ³ëÃâ µÈ °Í°ú ¹ÝÀÀÀÌ ÀϾ±â±îÁöÀÇ »çÀÌ ¶Ç´Â Áï°¢ÀûÀÎ Àڱذú ¹ÝÀÀÀÇ ½ÃÀÛ »çÀÌÀÇ ±â°£.
  • latent prostatic cancer
    Àü¸³»ù ÀáÀç ¾Ï
  • latent schizophrenia
    Àẹ ºÐ¿­º´
    1. Á¤½Åº´ÀûÀÎ Á¤½ÅºÐ¿­º´ÀÇ ±â¿Õ·ÂÀº ¾øÀ¸³ª Á¤½ÅºÐ¿­º´¿¡ °É¸± °¨¼ö¼ºÀÌ ÀÖ´Â °Í. 2. Á¤½ÅºÐ¿­ÁõÀÇ ±âº»ÀûÀÎ Áõ»óÀº Á¸ÀçÇϰí ÀÖÀ¸³ª ºÐ¸íÇÑ Á¤½Åº´ Áõ»óÀ¸·Î Ç¥¸éÈ­Çϰųª »çȸ»ýȰÀÇ ºÎÀûÀÀÀ» ÃÊ·¡ÇÏÁö ¾Ê´Â °Í.
  • latent state
    ÀáÀç »óÅÂ
    Àẹ±âÀÇ ±ÕÀÇ »óÅÂ. ±Õ ÀÚ½ÅÀÇ º´Àû Ư¼ºÀ» ¹ßÈÖÇÏÁö ¸øÇϰí ÀÖ´Â »óÅÂ.
  • latent trigger point
    ÀáÀ缺 ¹ßÅëÁ¡
  • latent zone
    Àẹ´ë
    ¼¼±ÕÀÇ ÀÏ»ý¿¡¼­ Àẹ±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
latent microbism The presence of pathogenic microorganisms in the body that elicit no symptoms; the condition of a pathogen carrier.
(05 Mar 2000)
latent nystagmus Jerky nystagmus that is brought out by covering one eye. The fast phase is always away from the covered eye.
(05 Mar 2000)
latent period A seemingly inactive period, as that between exposure of tissue to an injurious agent and the manifestation of response or that between the instant of stimulation and the beginning of response.
(18 Nov 1997)
latent rat virus A virus of the genus Parvovirus causing inapparent infection in rats; also recoverable from rat tumours.
Synonym: latent rat virus.
(05 Mar 2000)
latent reflex A reflex which must be considered normal but which usually appears only under some pathologic circumstance that lowers its threshold.
(05 Mar 2000)
latent schizophrenia A preexisting susceptibility for developing overt schizophrenia under strong emotional stress.
(05 Mar 2000)
latent stage incubation period
latent syphilis Infection with Treponema pallidum, after the manifestations of primary and secondary syphilis have subsided (or were never noticed), before any manifestations of tertiary syphilis have appeared.
(05 Mar 2000)
latent tetany A rather vague disorder recognised more in Europe than in the U.S. Consisting of a number of non-specific complaints, including generalised weakness, hand and foot cramping, distal paresthesia, anxiety, and depression. Some think it is a "normocalcaemic tetany"; others consider it "chronic hyperventilation syndrome." Typically with certain provoking procedures (e.g., limb ischemia, hyperventilation) in which case, obvious tetany develops.
See: Trousseau's sign, Chvostek's sign, Erb sign.
Synonym: crytotetany, spasmophilia.
(05 Mar 2000)
latent typhoid walking typhoid
latent virus <virology> Virus integrated within host genome but inactive: may be reactivated by stress such as ultraviolet irradiation.
(18 Nov 1997)
latent zone That portion of the cerebral cortex, the stimulation of which produces no movement and a lesion of which produces no symptoms; mainly the more anterior areas of the frontal lobes.
(05 Mar 2000)
acetoacetyl-acyl carrier protein synthase <enzyme> E coli enzyme, that catalyses condensation of malonyl-acyl carrier protein plus acetyl-acyl carrier protein; not inhibited by cerulenin
Registry number: EC 2.3.1.-
Synonym: acetoacetyl-acp synthase
(26 Jun 1999)
acyl-(acyl-carrier-protein)-phospholipid acyltransferase <enzyme> Catalyses the formation of phosphatidylethanolamine from acyl-acyl carrier protein and 2-acyl-sn-glycero-3-phosphoethanolamine
Registry number: EC 2.3.1.40
Synonym: 2-acyl-gpe acyltransferase, 2-acylglycerophosphoethanolamine acyltransferase
(26 Jun 1999)
acyl-(acyl-carrier-protein)-UDP-N-acetylglucosamine acyltransferase <enzyme> E coli enzyme involved in lipid a biosynthesis; uses beta-hydroxymyristoyl-acyl carrier protein to form udp-3-monoacyl-n-acetylglucosamine; amino acid sequence given in second source
Registry number: EC 2.3.1.129
Synonym: udp-aguatransferase, lpxa protein, udp-n-acetylglucosamine-3-acyltransferase, udp-n-acetylglucosamine 3-o-acyltransferase, udp-3-o-(r-3-hydroxymyristoyl)glucosamine-n-acyltransferase, lpxd protein, fira gene product, fira protein
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • common carrier
    ÀÏ¹Ý ¿î¼ö¾÷ÀÚ(öµµ.Ç×°øÈ¸»ç µî)
  • contract carrier
    °è¾à(Àü¼Ó)¼ö¼Û¾÷ÀÚ
  • escort carrier
    È£À§¿ë ¼ÒÇü Ç×°ø ¸ðÇÔ
  • flag carrier
    ÇÑ ³ª¶ó¸¦ ´ëÇ¥ÇÏ´Â Ç×°ø(¼±¹Ú)ȸ»ç
  • germ carrier
    º¸±ÕÀÚ
  • hod carrier
    hod¸¦ ³ª¸£´Â ÀκÎ
  • letter carrier
    ¿ìÆíÁý¹èÀÎ
  • mail carrier
    ¿ìÆí Áý¹è¿ø
  • minority carrier
    ¼Ò¼ö´ãü(¹ÝµµÃ¼ÀÇ)
  • personnel carrier
    ±º¼ö¼ÛÂ÷ 
  • torpedo carrier (plane)
    ³ú°Ý±â
  • troop carrier
    ±º´ë ¼ö¼Û±â(Â÷)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á